Paper7752190
Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)
Pettit GR and 6 others. J Med Chem, 1995. Cited by 302 papers, by iCite.
Cite this record
ConductScience Library. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a). Papers, record 7752190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7752190
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Plants, Medicinal | Major topic |
| Stilbenes | Major topic |
| Anti-Bacterial Agents | |
| Drug Screening Assays, Antitumor | |
| Microbial Sensitivity Tests | |
| Neisseria gonorrhoeae | |
| Structure-Activity Relationship | |
| Tumor Cells, Cultured |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 16049-05-12 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA 44344-01A1-06 | NCI NIH HHS | United States | PubMed | PubMed | |
| N01-CM-97262 | NCI NIH HHS | United States | N01CM097262 | PubMed and NIH | NIH RePORTER |
| R01CA016049 | NIH | NIH RePORTER | |||
| R35CA044344 | NIH | NIH RePORTER |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 302 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40927638 | Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40927638 | PubMed |
| 40427352 | Alternative Agents to Colcemid for Obtaining High-Quality Metaphase Spreads. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40427352 | PubMed |
| 39990814 | Design, synthesis, molecular docking and anticancer activity of benzothiazolecarbohydrazide-sulfonate conjugates: insights into ROS-induced DNA damage and tubulin polymerization inhibition. | RSC Adv | 2025 | https://conductscience.org/library/papers/39990814 | PubMed |
| 39970877 | First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/39970877 | PubMed |
| 39861179 | (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861179 | PubMed |
| 39860187 | Synthesis and Biological Evaluation of New cis-Restricted Triazole Analogues of Combretastatin A-4. | Molecules | 2025 | https://conductscience.org/library/papers/39860187 | PubMed |
| 38659489 | Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38659489 | PubMed |
| 38083880 | 3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents. | J Enzyme Inhib Med Chem | 2024 | https://conductscience.org/library/papers/38083880 | PubMed |
| 37111767 | Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111767 | PubMed |
| 36830175 | Ethnopharmacology, Antimicrobial Potency, and Phytochemistry of African Combretum and Pteleopsis Species (Combretaceae): A Review. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36830175 | PubMed |
| 36364041 | Copper-Catalyzed Diboron-Mediated cis-Semi-Hydrogenation of Alkynes under Facile Conditions. | Molecules | 2022 | https://conductscience.org/library/papers/36364041 | PubMed |
| 36320328 | An organometallic analogue of combretastatin A-4 and its apoptosis-inducing effects on lymphoma, leukemia and other tumor cells in vitro. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/36320328 | PubMed |
| 36142133 | The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142133 | PubMed |
| 35628467 | Photopharmacology of Antimitotic Agents. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628467 | PubMed |
| 35539660 | Diaryl ethers synthesis: nano-catalysts in carbon-oxygen cross-coupling reactions. | RSC Adv | 2018 | https://conductscience.org/library/papers/35539660 | PubMed |
| 35510306 | Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization. | Angew Chem Int Ed Engl | 2022 | https://conductscience.org/library/papers/35510306 | PubMed |
| 35263505 | Cyclobutanes in Small-Molecule Drug Candidates. | ChemMedChem | 2022 | https://conductscience.org/library/papers/35263505 | PubMed |
| 34959731 | New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3H)-benzothiazolones. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34959731 | PubMed |
| 34890803 | Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective. | Drug Discov Today | 2022 | https://conductscience.org/library/papers/34890803 | PubMed |
| 34832895 | New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832895 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7752190
GET https://conductscience.org/api/papers/v1/7752190/cited_by?page=2